Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFM) Depreciation & Amortization (IS) (2016 - 2024)

Historic Depreciation & Amortization (IS) for Sunshine Biopharma (SBFM) over the last 7 years, with Q1 2024 value amounting to $42618.0.

  • Sunshine Biopharma's Depreciation & Amortization (IS) rose 2278.31% to $42618.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $83911.0, marking a year-over-year increase of 8768.68%. This contributed to the annual value of $223527.0 for FY2024, which is 4987.03% up from last year.
  • According to the latest figures from Q1 2024, Sunshine Biopharma's Depreciation & Amortization (IS) is $42618.0, which was up 2278.31% from $34710.0 recorded in Q1 2023.
  • In the past 5 years, Sunshine Biopharma's Depreciation & Amortization (IS) registered a high of $42618.0 during Q1 2024, and its lowest value of $3110.0 during Q1 2022.
  • Its 3-year average for Depreciation & Amortization (IS) is $26812.7, with a median of $34710.0 in 2023.
  • Per our database at Business Quant, Sunshine Biopharma's Depreciation & Amortization (IS) surged by 101607.72% in 2023 and then skyrocketed by 2278.31% in 2024.
  • Quarter analysis of 3 years shows Sunshine Biopharma's Depreciation & Amortization (IS) stood at $3110.0 in 2022, then surged by 1016.08% to $34710.0 in 2023, then grew by 22.78% to $42618.0 in 2024.
  • Its Depreciation & Amortization (IS) stands at $42618.0 for Q1 2024, versus $34710.0 for Q1 2023 and $3110.0 for Q1 2022.